Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Cladribine After Natalizumab for Multiple Sclerosis
Recruiting3 awardsPhase 4
Overland Park, Kansas
This trial will assess the safety and efficacy of the drug cladribine after treatment with natalizumab in patients with RRMS and active SPMS.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.